In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin

Mycoses

Volumn 41, Issue 7-8, 1998, Pages 309-319

  Wildfeuer, A ^a,c   Seidl, H P ^b   Paule, I ^a   Haberreiter, A ^a  

^a PFIZER INC   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c NONE   (Germany)

Author keywords

Amphotericin B; Antifungals; Griseofulvin; In vitro activity; Itraconazole; Ketoconazole; Voriconazole

Indexed keywords

AMPHOTERICIN B; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; VORICONAZOLE;

ABSIDIA; ACREMONIUM; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CHRYSOSPORIUM; CLADOSPORIUM; CONTROLLED STUDY; DERMATOPHYTE; DRUG EFFICACY; DRUG SENSITIVITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOULD; MUCOR; NONHUMAN; PRIORITY JOURNAL; RHIZOPUS; YEAST; ZYGOMYCETES;

ABSIDIA; ALTERNARIA; ARTHRODERMATACEAE; ASPERGILLUS; ASPERGILLUS FUMIGATUS; CHRYSOSPORIUM; CLADOSPORIUM; FUSARIUM; MUCOR; RHIZOPUS; STAPHYLOCOCCUS PHAGE 187; ZYGOMYCETES;

EID: 0031797483     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.1998.tb00344.x     Document Type: Article

References (25)

1. Morrison, V. A., Haake, R. J. & Weisdorf, D. J. (1994) Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. Am. J. Med. 96, 497-503.
2. Bodey, G., Bueltmann, B., Dugid, W., et al. (1992) Fungal infections in cancer patients: an international autopsy survey. Eur J. Clin. Microbiol. Infect. Dis. 11, 99-109.
3. Denning, D. W. (1996) Therapeutic outcome in invasive aspergillosis. Clin. Infect. Dis. 23, 608-615.
4. Denning, D. W., Lee, J. Y., Hostetler, J. S., et al. (1994) NIAID mycoses study group multicenter trial of oral itraconaxole therapy for invasive aspergillosis. Am. J. Med. 97, 135-144.
5. Barriere, S. L. (1990) Pharmacology and pharmacokinetics of traditional systemic antifungal agents. Pharmacotherapy 10, 134-140.
6. Como, J. A. & Dismukes, W. E. (1994) Oral azole drugs as systemic antifungal therapy. N. Engl. J. Med. 4, 263-272.
7. Kauffmann, C. A. & Carver, P. L. (1997) Antifungal agents in the 1990s. Drugs 53, 539-549.
8. Powderly, W. G., Saag, M. S., Cloud, G. A., et al. (1992) A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 326, 793-798.
9. Rex, J. H., Bennett, J. E., Sugar, A. M. et al. (1994) A randomised trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N. Engl. J. Med. 331, 1325-1330.
10. Just-Nübling, G., Gentschew, G., Döhle, M., Bottinger, C., Helm, E. B. & Stille, W. (1990) Fluconazole in the treatment of oropharyngeal candidosis in HIV-positive patients. mycoses 33, 435-440.
11. Kotogyan, A., Harmanyeri, Y., Tahsin Gunes, A. et al. (1996) Efficacy and safety of oral fluconazole in the treatment of patients with tinea corporis, cruris or pedis or cutaneous candidosis. Clin. Drug Invest. 12, 59-66.
12. Wildfeuer, A., Seidl, H. P., Paule, I. & Haberreiter, A. (1998) In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin. Arzneim.-Forsch./Drug Res. 47, 1257-1263.
13. Smith, D., van de Velde, V., Woestenborghs, R. & Gazzard, B. G. (1992) The pharmacokinetics of oral itraconazole in AIDS patients. J. Pharm. Pharmacol. 44, 618-619.
14. Kintzel, P. E., Rollins, C. J., Yee, W. J. & List, A. F. (1995) Low itraconazole serum concentrations following administration of itraconazole suspension to critically ill allogeneic bone marrow transplant recipients. Ann. Pharmacother. 29, 140-143.
15. Denning, D., del Favero, A., Gluckman, E., et al. (1995) UK-109, 496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: clinical efficacy in acute invasive aspergillosis. Abstracts of the 35th ICAAC.
16. Dupont, B., Denning, D., Lode, H., Yonren, S., Troke, P. & Sarantis, N. (1995) UK-109, 496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: clinical ellicacy in chronic invasive aspergillosis. Abstracts of the 35th ICAAC.
17. Troke, P. F., Brammer, K. W., Hitchcock, C. A., Yonren, S. & Sarantis, N. (1995) UK-109, 496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: activity in systemic candidiasis models and early clinical efficacy in oropharyngeal candidiasis (OPC). Abstracts of the 35th ICAAC.
18. Patterson, B. E. & Coates, P. E. (1995) UK-109, 496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: pharmacokinetics in man. Abstracts of the 35th ICAAC.
19. Hitchcock, C. A., Pye, G. W., Oliver, G. P. & Troke, P. F. (1995) UK-109, 496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: antifungal activity and selectivity in vitro. Abstracts of the 35th ICAAC.
20. Wildfeuer, A. & Seidl, H. P. (1994) The in vitro activity of fluconazole against fungi involved in dermatological infections. mycoses 37, 447-449.
21. Dickinson, R. P., Bell, A. S., Hitchcock, C. A., Narayanaswami, S., Ray, S. J., Richardson, K. & Troke, P. F. (1996) Novel antifungal 2 aryl-1-(1H-1, 2, 4-triazol-1-YL) butan-2-OL derivatives with high activity against Aspergillus fumigatus. Bioorgan. Med. Chem. Lett. 16, 2031-2036.
22. McGinnis, M. R., Pasarell, L., Sutton, D. A., Fothergill, A. W., Cooper, C. R. & Rinaldi, M. G. (1997) In vitro evaluation of voriconazole against some clinically important fungi. Antimicrob. Agents Chemother. 41, 1832-1834.
23. Radford, S. A., Johnson, E. M. & Warnock, D. W. (1997) In vitro studies of activity of voriconazole (UK-109, 496), a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob. Agents Chemother. 41, 841-843.
24. Gamis, A. S., Gudnason, T., Giebink, G. S. & Ramsay, N. K. C. (1991) Disseminated infection with fusarium in recipients of bone marrow transplants. Rev. Infect. Dis. 13, 1077-1088.
25. Barry, A. L. & Brown, S. D. (1996) In vitro studies of two triazole antifungal agents (voriconazole [UK-109, 496] and fluconazole) against Candida species. Antimicrob. Agents Chemother. 40, 1948-1949.